# FDA recall D-0166-2021

> **Torrent Pharma Inc** · Class I · drug recall initiated 2020-11-25.

## Product

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide USA and Puerto Rico

## Key facts

- **Recall number:** D-0166-2021
- **Recalling firm:** Torrent Pharma Inc
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-11-25
- **Report date:** 2020-12-09
- **Termination date:** 2022-12-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Levittown, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0166-2021

## Citation

> AI Analytics. FDA recall D-0166-2021. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0166-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*